158 related articles for article (PubMed ID: 37620622)
1. High-dose ascorbic acid potentiates immune modulation through STAT1 phosphorylation inhibition and negative regulation of PD-L1 in experimental sepsis.
Zhang X; Ji W; Deng X; Bo L
Inflammopharmacology; 2024 Feb; 32(1):537-550. PubMed ID: 37620622
[TBL] [Abstract][Full Text] [Related]
2. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
Hu YM; Hsiung YC; Pai MH; Yeh SL
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
[TBL] [Abstract][Full Text] [Related]
3. PKM2/STAT1-mediated PD-L1 upregulation on neutrophils during sepsis promotes neutrophil organ accumulation by serving an anti-apoptotic role.
Li Y; Tan R; Li R; Tian R; Liu Z; Wang X; Chen E; Pan T; Qu H
J Inflamm (Lond); 2023 May; 20(1):16. PubMed ID: 37131151
[TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
Li W; Tu J; Liu X; Yang W
Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
[TBL] [Abstract][Full Text] [Related]
5. MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice.
Zhen J; Chen W
Biomed Pharmacother; 2018 Jan; 97():1479-1485. PubMed ID: 29793310
[TBL] [Abstract][Full Text] [Related]
6. The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis.
Deng W; Zhu S; Zeng L; Liu J; Kang R; Yang M; Cao L; Wang H; Billiar TR; Jiang J; Xie M; Tang D
Cell Rep; 2018 Jul; 24(2):366-378. PubMed ID: 29996098
[TBL] [Abstract][Full Text] [Related]
7. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.
Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333
[TBL] [Abstract][Full Text] [Related]
8. Splenic T lymphocytes induce the formation of immunosuppressive neutrophils through IFN-γ in sepsis.
Huang J; Sun R; Yang Y; Li L; Liu L; Shao Y; Ji D; Sun B
Inflamm Res; 2022 Jan; 71(1):81-91. PubMed ID: 34841450
[TBL] [Abstract][Full Text] [Related]
9. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression.
Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z
Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183
[TBL] [Abstract][Full Text] [Related]
10. Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis.
Wang F; Huang X; Chung CS; Chen Y; Hutchins NA; Ayala A
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G237-45. PubMed ID: 27288425
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with probiotics and anti-PD-L1 antibody synergistically ameliorates sepsis in mouse model.
Sun L; Fang K; Yang Z
Heliyon; 2024 Jun; 10(11):e31747. PubMed ID: 38828304
[TBL] [Abstract][Full Text] [Related]
12. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis.
Wang JF; Wang YP; Xie J; Zhao ZZ; Gupta S; Guo Y; Jia SH; Parodo J; Marshall JC; Deng XM
Blood; 2021 Sep; 138(9):806-810. PubMed ID: 34473230
[TBL] [Abstract][Full Text] [Related]
13. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction.
Zhang Y; Zhou Y; Lou J; Li J; Bo L; Zhu K; Wan X; Deng X; Cai Z
Crit Care; 2010; 14(6):R220. PubMed ID: 21118528
[TBL] [Abstract][Full Text] [Related]
15. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].
Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331
[TBL] [Abstract][Full Text] [Related]
16. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
17. Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic Acute Renal Injury.
Xu J; Ma X; Yu K; Wang R; Wang S; Liu R; Liu H; Gao H; Yu K; Wang C
J Microbiol Immunol Infect; 2021 Jun; 54(3):404-410. PubMed ID: 31727535
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model.
Zhu W; Bao R; Fan X; Tao T; Zhu J; Wang J; Li J; Bo L; Deng X
Mediators Inflamm; 2013; 2013():361501. PubMed ID: 24324295
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice.
Zhao ZZ; Wang XL; Xie J; Chen LP; Li Q; Wang XX; Wang JF; Deng XM
Med Sci Monit; 2021 Jan; 27():e926820. PubMed ID: 33421049
[TBL] [Abstract][Full Text] [Related]
20. A novel immunomodulatory function of PHLPP1: inhibition of iNOS via attenuation of STAT1 ser727 phosphorylation in mouse macrophages.
Alamuru NP; Behera S; Butchar JP; Tridandapani S; Kaimal Suraj S; Babu PP; Hasnain SE; Ehtesham NZ; Parsa KV
J Leukoc Biol; 2014 May; 95(5):775-783. PubMed ID: 24443556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
